PTH and hypercalcemia disease: Upon binding with the Vitamin D receptor, 1,25-dihydroxyvitamin D3(1,25D) directly inhibits parathyroid hormone gene transcription and antagonizes osteocalcin to prevent hypercalcemia (29).